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Background. Decubitus ulcers can become complicated by pelvic osteomyelitis. Little is known about the epi-
demiology of pressure ulcer-related pelvic osteomyelitis.
Methods. We performed a retrospective cohort study of adult patients with pressure ulcer and pelvic osteomy-
elitis admitted to an academic center from 2006 to 2011. Data on clinical presentation, diagnostic evaluation, and
treatment during the index admission were collected. Outcome measures included length of hospital stay and num-
ber of readmissions in the subsequent year.
Results. Two hundred twenty patients were included: 163 (74%) were para/quadriplegic and 148 (67%) were
male (148; 67%). Mean age was 50 (±18) years. Pelvic osteomyelitis was the primary admission diagnosis for 117
(53%). Fifty-six (26%) patients had concurrent febrile urinary tract infection. Wound cultures collected for 113 pa-
tients (51%) were notable for methicillin-resistant Staphylococcus aureus (37; 33%), Streptococci (19; 17%), and Pseu-
domonas spp (20; 18%). Plain ﬁlms were obtained in 89 (40%) patients, computed tomography scans were obtained
for 81 (37%) patients, and magnetic resonance images were obtained for 40 (18%) patients. Most patients received
osteomyelitis-directed antibiotics (153; 70%), 134 of 153 (88%) of which were scheduled to receive ≥6 weeks of treat-
ment. Fifty-ﬁve (25%) patients underwent surgery during the index admission; 48 (22%) patients received a com-
bined medical-surgical approach. One third of patients had ≥2 readmissions during the subsequent year. Patients
treated with a combined approach were less likely to be readmitted than those who received antibiotics alone
(0 [range, 0–4] vs 1 [0–7] readmissions; P = .04).
Conclusions. This is one of the largest cohort studies of pressure ulcer-related pelvic osteomyelitis to date. Sig-
niﬁcant variations existed in diagnostic approach. Most patients received antibiotics; those treated with a combined
medical-surgical approach had fewer hospital readmissions.
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Patients with neurological diseases are prone to devel-
op pressure ulcers due to their sensory and motor
impairment resulting in immobility. Left untreated,
these ulcers can eventually extend to the bone (in
which case they are classiﬁed as stage IV pressure
ulcers [1]) and be associated with infectious complica-
tions such as soft tissue infection or osteomyelitis. Os-
teomyelitis is thought to occur in approximately one
third of these ulcers [2]. Stage IV pressure ulcers
most commonly affect the tissue overlying the sacrum,
ischial bones, and femoral heads, and therefore pres-
sure ulcer-related osteomyelitis is typically found in
these locations [3].
Pressure ulcer-related osteomyelitis is challenging to
manage for a number of reasons. First, our diagnostic
tools are limited, and it can be difﬁcult to differentiate
a pressure sore with underlying osteomyelitis from a
soft tissue infection surrounding the ulcer, simple mi-
crobial colonization of the ulcer, or noninfectious
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pressure-related bone changes underneath an ulcer [4]. Sec-
ond, radiological studies are hard to interpret, and they do
not necessarily permit a distinction between presence and ab-
sence of infection, acute and chronic forms of osteomyelitis, or
persistent and resolving infection [5]. Third, patients with spi-
nal cord injury are often unable to report local pain, which is a
useful tool for monitoring treatment response in other patient
populations. Fourth, chronic osteomyelitis may not be curable
with antibiotic treatment alone but may require concomitant
surgical measures [6]. Lastly, chronic wounds facilitate the
entry of further pathogens and can lead to recurrent episodes
of infection.
From an economic viewpoint, there is a signiﬁcant ﬁnancial
burden associated with stage IV pressure ulcers, particularly in
those patients in which ulcers progress to infection of the un-
derlying bone. The average cost for patients with pressure ulcers
necessitating 4 consecutive admissions exceeds $100 000 [7]. In
addition, the psychological impact of having a smoldering bone
infection that may require multiple hospital admissions, treat-
ment courses, and assiduous wound care, all the while threaten-
ing slow destruction of tissues has, to our knowledge, never
been studied.
Despite the gaps in knowledge, only a few clinical and epide-
miological studies have examined pressure ulcer-related pelvic
osteomyelitis [2–4, 8, 9]. It is a neglected disease of the devel-
oped world. The goal of our study was to describe the epidemi-
ology of pressure ulcer-related pelvic osteomyelitis, including
the clinical presentation, diagnostics, management, and out-
comes of this understudied condition.
METHODS
Study Design and Setting
We performed a 6-year, retrospective cohort study of patients
admitted to Barnes-Jewish Hospital (BJH) between June 1,
2006 and July 31, 2011 and diagnosed with pressure ulcer-related
pelvic osteomyelitis. Barnes-Jewish Hospital, a 1250-bed teach-
ing hospital, is the largest hospital in Missouri, with a referral
base that draws from the St. Louis metropolitan area, eastern
Missouri, and southwestern Illinois. We used a medical infor-
matics database to identify all discharges with ICD-9-CM
codes for both pressure ulcers (707–707.9) and osteomyelitis
(730–730.9). These discharges were then reviewed to determine
whether they met study inclusion criteria deﬁned below. Only
the ﬁrst admission of an individual patient was considered,
whereas readmissions were part of the outcomes evaluation.
The study was approved by the Washington University Human
Research Protection Ofﬁce.
Inclusion and Exclusion Criteria
Patients ≥18 years old admitted to the hospital with stage
IV pressure ulcer present at the time of diagnosis of pelvic
osteomyelitis. We excluded pelvic osteomyelitis patients with
stage I–III ulcers.
Data Collection and Deﬁnitions
We reviewed medical records of all patients who met inclusion
criteria. Medical records were examined for demographic infor-
mation, comorbidities, antibiotic history, presenting symptoms,
vital signs, and physical examination ﬁndings, imaging studies,
diagnostic procedures, microbiology, and both medical and sur-
gical treatment. Laboratory values (such as C-reactive protein
and erythrocyte sedimentation rate) and temperature data with-
in 24 hours of admission were also collected.
Length of hospital stay, transfer to the intensive care unit, and
crude in-hospital mortality were some of the outcomes of inter-
est. We took the number of readmissions over the following 12
months as the primary endpoint; all patients had at least 12
months of follow-up time to determine this outcome. Cure is a
standard clinical outcome; however, it is difﬁcult to ascertain in
neurologically compromised patients. In addition, wound docu-
mentation over the course of hospitalization(s) was poor; there-
fore, we chose not to include this in our selection of outcomes.
We deﬁned renal insufﬁciency as serum creatinine of >2.0
mg/dL. Active malignancy was deﬁned as having received che-
motherapy or radiation therapy for cancer in the previous 6
months.
Statistical Analysis
Data entry was performed using Microsoft Access and Excel (Mi-
crosoft Corp., Redmond, WA), and we analyzed the data using
SPSS 17 (SPSS Inc., Chicago, IL). Univariate comparisons among
categorical variables were done with the χ2 test or Fisher’s exact test,
as appropriate. Comparisons among continuous variables were
performed using Student’s t test orMann-WhitneyU test, as appro-
priate. We considered a 2-sided P value <.05 to be signiﬁcant.
RESULTS
Patient Characteristics and Clinical Presentation
Of the 270 adult patients with discharge ICD-9-CM codes for
pelvic osteomyelitis during the 6-year study period, 220 (81%)
were diagnosed with both pressure ulcer and pelvic osteomyeli-
tis and met study criteria (Table 1). The mean age was 50 years
(standard deviation ±18). Patients were mostly male (n = 148;
67%) and African American (n = 114; 52%). The median
body mass index was 23.6 kg/m2 (range, 12.3–48.0). Sixteen
(7%) patients had been transferred from an outside hospital
to our institution; all others were direct admissions.
One hundred seventy (77%) patients were para/quadriplegic,
whereas 50 (23%) had no documented neurological dysfunction
(ie, they had alternative explanations for their immobility). Of
the 170 para/quadriplegic patients, 120 (55%) had traumatic
paraplegia; 30 (14%) had a history of cerebrovascular accident;
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and 20 (9%) patients had a congenital central nervous system
abnormality. Diabetes mellitus (18%) and chronic renal insufﬁ-
ciency (11%) were the 2 leading comorbidities among our study
patients. Only 117 (53%) patients were primarily admitted for
pelvic osteomyelitis; for the remainder, it was a secondary diag-
nosis. Fifty-six (26%) patients had a concurrent urinary tract in-
fection (UTI), and 32 (15%) had bacteremia. Only 113 (51%)
patients had wound documentation; 84 (74%) of these had
wound drainage, and 49 (43%) explicitly had purulent drainage
from the ulcer. Weakness (74%), sensory loss (71%), and urine
incontinence (71%) were the most frequently reported symp-
toms on admission; subjective fevers (43%) and weight loss
(40%) were less commonly disclosed. Most of our patients
(n = 174, 79%) did not have a documented neurological exam
upon admission. However, 44 (20%) patients had impaired
motor strength and 40 (18%) patients had sensory deﬁcits, re-
ﬂecting their underlying neurological condition.
Diagnostic Evaluation
One hundred sixty-eight (76.4%) patients underwent at least 1
radiological evaluation during their hospitalization. Plain
radiography was the most common diagnostic evaluation that
patients had undergone in this cohort (n = 89; 40.4%); radiolog-
ic evaluations of 55 of these 89 (61.8%) patients were read as
consistent with pelvic osteomyelitis. Computed tomography
(CT) scans were obtained for 81 (37%) patients, 83% of which
were consistent with pelvic osteomyelitis, and magnetic reso-
nance images (MRI) were obtained for 40 (18%) patients
(88% consistent with pelvic osteomyelitis). Few patients were
classiﬁed as having acute pelvic osteomyelitis by the radiologist
based on imaging ﬁndings (19; 9%).
Basic laboratory values are reported in Table 2. In terms of
microbiological work-up, patients had either a superﬁcial,
deep tissue, or bone culture (or a combination of these) taken.
Of the 113 (51%) patients for which we encountered microbiol-
ogy results, only 23 (20%) had bone biopsies taken (ie, the gold
standard); for 26 (23%) patients, deep tissue cultures were ob-
tained; and for the majority of patients, 64 (57%), wound cul-
tures were submitted. In some instances, samples from multiple
sites were taken; in these cases, bone biopsies were valued high-
er than other specimens. Commonly detected organisms in-
cluded methicillin-resistant Staphylococcus aureus (MRSA)
(26; 23%), Streptococcus spp (19; 17%), Pseudomonas spp (20;
18%), and methicillin-susceptible S aureus (MSSA) (11; 10%).
In 34 (30%) patients, multiple organisms were identiﬁed; in ad-
dition, in 29 of 46 (63%) patients with a single organism, work-
up elicited additional, mixed ﬂora that was not processed
further. Cultures did not reveal microbial growth in 33 (29%)
patients (Table 3). Few pathogens were identiﬁed from bone
Table 1. Patient Characteristics and Clinical Presentation in 220
Cases of Pressure Ulcer-Related Pelvic Osteomyelitis
Demographic Variable n (%)
Age (mean±SD), years 50 (±18)
Male gender 148 (67%)
African American race 114 (52)
Body mass index (median, range), kg/m2 23.6 (12.3–48.0)
Transfer from outside hospital 16 (7%)
Neurological causes/etiology
Trauma (history of spinal injury) 120 (55%)
Cerebrovascular accident 30 (14%)
Congenital CNS abnormality 20 (9%)
Nonneurological comorbidity
Diabetes mellitus 39 (18%)
Chronic renal insufficiency (serum creatinine >1.5) 23 (11%)
Malignancy 18 (8%)
HIV infection 1 (1%)
Reported symptoms
Back pain 68 (31%)
Weakness 163 (74%)
Fever 95 (43%)
Weight loss 88 (40%)
Sensory loss 156 (71%)
Urine incontinence 155 (71%)
Stool incontinence 144 (61%)
Physical findings
No documentation of neurological exam 174 (79%)
No documentation of wound exam 113 (51%)
Abbreviations: CNS, central nervous system; HIV, human immunodeficiency
virus; SD, standard deviation.
Table 2. Diagnostic Work-Up of 220 Patients With Pressure
Ulcer-Related Pelvic Osteomyelitis
Variable
Mean
(±SD)
Compatible With
Infection (%)
Laboratory data
WBC count (mean, SD), k/mm3 13 (7)
ESR (mean, standard
deviation), mm/h
78 (30)
CRP (mean, standard
deviation), mg/dL
116 (83)
Diagnostic work-up
Radiology
Pelvic x-ray 89 (41%) 62%
CT scan 81 (37%) 83%
MRI 40 (18%) 88%
Bone scan 19 (9%) 79%
Any culture 113 (51%)
Wound culture 64 (29%)
Deep tissue culture 26 (12%)
Bone culture 23 (11%)
Abbreviations: CRP, C-reactive protein; CT, computed tomography; ESR,
erythrocyte sedimentation rate; MRI, magnetic resonance imaging; SD,
standard deviation; WBC, white blood cell count.
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cultures: only 12 of 23 (52%) bone cultures taken revealed
a pathogen. For patients who did not undergo imaging nor
microbiological sampling, the diagnosis of osteomyelitis was
made based on clinical grounds (eg, visible exposure of bone
or positive probe-to-bone test).
Management and Outcomes
An Infectious Diseases (ID) consult was obtained to guide the
management of pelvic osteomyelitis in 143 (65%) patients dur-
ing the index hospitalization. The mean time from admission to
ﬁrst positive culture was 2.3 days; the mean time from admis-
sion to empiric antibiotic therapy was slightly shorter at 2.1
days. Among those patients with positive bone cultures, 92% re-
ceived antibiotic therapy, compared with 84% of those with
deep tissue or wound cultures (P = .7). Most patients received
osteomyelitis-directed antibiotics (153; 70%); for 105 patients,
this was the only modality used to treat the osteomyelitis.
One hundred thirty-four of 153 (88%) patients were scheduled
to receive ≥6 weeks of antibiotics. Fifty-ﬁve (25%) patients un-
derwent surgery; all underwent surgical debridement and 7 of
55 (12.7%) also received myocutaneous ﬂap coverage. Forty-
eight (22%) patients received combined therapy. Almost one
third of patients (31.3%) had 2 or more readmissions at our cen-
ter in the course of the following year; 51 (23.2%) had a single
readmission; and 100 (45.5%) did not require readmission at
BJH. There was no difference in number of readmissions
based on whether patients had been seen by the ID consult ser-
vice or not (1.3 [±1.7] vs 1.1 [±1.4] readmissions; P = .5). In ad-
dition, administering an MRI during the diagnostic work-up
did not inﬂuence this outcome (1.0 [±1.3] vs 1.3 [±1.7] read-
missions; P = .4). Patients treated with a combined medical-
surgical approach were less likely to be readmitted compared
with those patients who received antibiotics alone (Table 4).
There was no difference in length of hospital stay between the 2
groups (8.5 days [1–94] in those treated with a combined approach
vs 7 days [2–84] in those treated with antibiotics alone; P = .1).
DISCUSSION
Pressure ulcer-related pelvic osteomyelitis predominantly af-
fects those patients with traumatic spinal cord injury and a his-
tory of cerebrovascular accident. Few studies have attempted to
describe the epidemiology of this neglected disease, although it
is associated with substantial morbidity and represents a signiﬁ-
cant economic burden to society. In this study, we report ﬁnd-
ings from a comparatively large observational study of patients
with pressure ulcer-related pelvic osteomyelitis. Wound docu-
mentation was poor, which made monitoring the clinical
response to wound care, antibiotic treatment, and surgery a
challenge. There was considerable variation in diagnostic and
treatment approaches, suggesting that there are opportunities
for optimizing care.
In this study, pressure ulcers associated with pelvic osteomy-
elitis were documented in only 51% of cases. To demonstrate
changes over time, baseline wound documentation is essential.
This becomes most evident when attempting to deﬁne treat-
ment success. In light of poor wound documentation not only
at baseline but also during the remainder of an admission, we
were unable to determine clinical success (expressed as wound
improvement) in this retrospective cohort, and therefore we did
not include it as an endpoint. In a review of the literature, Ren-
nert et al [2] argue that all affected patients should undergo
standardized wound documentation that includes baseline
and follow-up wound photography, thereby facilitating out-
come studies.
Most patients underwent at least 1 radiographic evaluation
during their hospitalization; plain radiography was the most
common imaging study used in our institution, but it was
only conﬁrmatory of osteomyelitis in approximately 60% of
cases. The likelihood of CT and MRI results being consistent
with bone infection was higher (82% and 88%, respectively),
but these studies focused on smaller subgroups in our cohort.
Table 3. Microbiology of 113 Cases of Pressure Ulcer-Related
Pelvic Osteomyelitis With Bone Cultures, Deep Tissue Cultures,
or Wound Cultures
Organism Detected Monomicrobial, n (%)
MSSA 6 (5%)
MRSA 15 (13%)
Streptococcus spp 9 (8%)
Escherichia coli 0 (0%)
Pseudomonas aeruginosa 4 (4%)
Enterococcus spp 3 (3%)
Others 9 (8%)
Mixed 34 (30%)
No growth 33 (29%)
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA,
methicillin-sensitive Staphylococcus aureus.
Table 4. Treatments and Outcomes of Chronic Pressure Ulcer
Patients
Treatment n (%)
Number of
Readmissions
(Median, Range)
Total Length
of Hospital
Stay (Median,
Range)
Antibiotics only 105 (47.7%) 1 (0–7) 7 (2–84)
Surgical Procedure
only
7 (3.2%) 2 (0–5)
Combined
medical-surgical
approach
48 (21.8%) 0 (0–4) 8.5 (1–94)
None 60 (27.3%) 1 (0–9)
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The role of imaging is poorly deﬁned and has never been scru-
tinized with regards to cost-effectiveness. It is possible that the
most relevant aspect of imaging is to assess the extent of affected
bone for the purpose of planning surgical debridement [5]. In
contrast, an autopsy-based study suggested that radiology leads
to overestimation of affected tissue [10]. In our cohort, obtain-
ing an MRI, the most sensitive imaging tool, did not affect the
readmission rate. This is similar to another group’s ﬁndings
[11]. A disadvantage of our cohort was that histopathology,
the gold standard for diagnosing osteomyelitis studied else-
where [12], was not obtained systematically.
Obtaining a microbiological diagnosis is crucial given the
need for prolonged antibiotic therapy and the potential for in-
creased cost, toxicity, and other adverse events associated with
antibiotic therapy. Few previous studies have collected informa-
tion on the microbiology of pelvic osteomyelitis [4, 6], but the
spectrum seems to be broad and includes Gram-negative bacte-
ria. In our analysis, the most frequently detected organisms were
S aureus (both MRSA and MSSA), Streptococcus species, and
Pseudomonas aeruginosa. Polymicrobial osteomyelitis and in-
fections where only a single organism was speciated among
mixed ﬂora were common. The relative importance of different
specimens for optimally guiding therapy has not been deter-
mined; in our experience, the available cultures were used irre-
spective of whether they were obtained from bone, deep tissue,
or superﬁcial wound cultures.
The majority of the patients (68%) in our cohort received os-
teomyelitis-directed antibiotic therapy. One ﬁfth of the patients
received a combination of antibiotic therapy and surgical revi-
sion; few patients underwent surgery alone. This exempliﬁes the
wide array of approaches pursued in treating pressure ulcer-
related osteomyelitis and points to a lack of treatment studies
or consensus in the ﬁeld. Patients treated with a combined ap-
proach consisting of antibiotic treatment and surgery, however,
were less likely to be readmitted compared with those patients
who received antibiotic therapy alone. To our knowledge, this
has not been shown before, even though experts have advised
combined approaches in earlier studies [13]. In a mechanistic
approach, it makes sense that removal of infected and/or dead
bone along with systemic antibiotics is accompanied by the
highest treatment success rates. Future studies should include
additional outcome measures to better document the superior-
ity of combined medical-surgical approaches and consider
using propensity score analyses to avoid selection bias. One
rare example of evaluating novel approaches is a study by
Marriott et al [9], where a short course of antibiotic treatment
in conjunction with debridement was shown to be a useful
treatment option.
A large proportion of our study population comprised vic-
tims of ﬁrearms-related injuries. Patients who are conﬁned to
wheelchairs or permanently bedridden depend on care deliv-
ered by family members, partners, and healthcare providers
alike, and they are frequently admitted to healthcare institutions
in relatively quick succession, often with suspected infections of
unknown etiology. As such, pelvic osteomyelitis is very much a
societal problem in our metropolitan region with signiﬁcant
ﬁnancial implications. The burden to society—in terms of psy-
chological impact, loss of quality of life and residual function-
ality, involvement of voluntary caregivers, and healthcare cost
due to inpatient and outpatient care—should be accurately de-
termined in a future analysis. Pressure ulcer-related pelvic oste-
omyelitis is, to co-opt a label associated with tropical diseases in
developing countries, a neglected infection of the developed
world.
There are a few limitations to this study. We used a retrospec-
tive cohort of pressure ulcer-related pelvic osteomyelitis with in-
formation derived from their ﬁrst admission during the study
period. We did this because readmissions are common in this
patient population, and we wanted to avoid including multiple
hospital episodes related to the same infection in a given pa-
tient. The data are derived from a single academic tertiary
care center, which may limit its generalizability. Debridement
performed in the operating room was considered a surgical in-
tervention. All patients reported to have undergone surgery had
this procedure done. Pressure ulcers and exposed bone may also
be surgically debrided at the bedside; documentation of these
procedures in the medical record is often lacking based on
our clinical experience, yet it is potentially important for treat-
ment success as well. Therefore, the true number of patients that
received surgical debridement in our cohort could have been
higher than what we identiﬁed. Patients included in this study
also had to have at least 12 months of follow-up time within our
health system, as evidenced by subsequent health encounters
documented in our medical record, to examine the primary out-
come of readmission. It is possible that we could have inadver-
tently excluded sicker patients with poor outcomes who may
have died before these encounters could take place. Patients
also could have received care outside of our medical center,
which could have limited the reliability of our assessment of
outcomes. Study inclusion was based on ICD-9-CM discharge
diagnosis codes; undercoding for pressure ulcers or pelvic oste-
omyelitis could have resulted in missed cases. Because function-
al improvement cannot be used as an endpoint in spinal cord
injury, we also had to rely on alternative outcome measures,
namely hospital readmission, which may not have been speciﬁc
to complications related to pressure ulcers or pelvic osteomye-
litis given the multiple underlying medical comorbidities pre-
sent in our study cohort.
CONCLUSIONS
This is one of the largest cohort studies of pressure ulcer-related
pelvic osteomyelitis to date, and it reveals many gaps in our un-
derstanding of this neglected disease and its management.
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Concurrent UTI was common, making it difﬁcult to determine
the cause for a patient’s deterioration and, ultimately, hospital-
ization, in many cases. Half of all pressure sores were inade-
quately documented, and signiﬁcant variation existed in the
diagnostic approach to suspected osteomyelitis. Most patients
received antibiotic therapy; however, those treated with a com-
bined medical-surgical approach fared better in that they had
fewer hospital readmissions over the following year. Future
studies should determine the ﬁnancial and societal impact of
pelvic osteomyelitis, develop novel wound documentation tools
(eg, colorimetric assays), deﬁne reliable and readily measurable
outcome parameters, and test multidisciplinary treatment strat-
egies to improve long-term morbidity and prognosis associated
with this potentially devastating infection.
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